subject area of
-
Deferiprone in
F riedreich ataxia: A 6‐Month randomized controlled trial Journal Articles - Deferiprone-related arthropathy of the knee in a thalassemic patient: report of a case and review of the literature Journal Articles
- Effect of Age at the Start of Iron Chelation Therapy on Gonadal Function in β-Thalassemia Major Journal Articles
- Effects of iron binding agents on Saccharomyces cerevisiae growth and cytochrome P450 content Journal Articles
- Fanconi Syndrome Secondary to Deferasirox in Diamond-Blackfan Anemia: Case Series and Recommendations for Early Diagnosis Journal Articles
- Inflammation and oxidant-stress in -thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial Journal Articles
- Iron chelation therapy in patients with low‐ to intermediate‐risk myelodysplastic syndrome: A systematic review and meta‐analysis Journal Articles
- Iron overload in myelodysplastic syndromes: A Canadian consensus guideline Journal Articles
- Iron promotes cadmium binding to citrate. Journal Articles
- Lack of progressive hepatic fibrosis during long-term therapy with deferiprone in subjects with transfusion-dependent beta-thalassemia Journal Articles
- Metal-Induced Isomerization Yields an Intracellular Chelator that Disrupts Bacterial Iron Homeostasis Journal Articles
-
Overall survival in lower
IPSS riskMDS by receipt of iron chelation therapy, adjusting for patient‐related factors and measuring from time of first red blood cell transfusion dependence: anMDS ‐CAN analysis Journal Articles - The use of skin Fe levels as a surrogate marker for organ Fe levels, to monitor treatment in cases of iron overload Journal Articles
- Thiostrepton Hijacks Pyoverdine Receptors To Inhibit Growth of Pseudomonas aeruginosa Journal Articles
- Transcriptional effects of hypoxia on fusiogenic syncytin and its receptor ASCT2 in human cytotrophoblast BeWo cells and in ex vivo perfused placental cotyledons Journal Articles